Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Dasatinib
Medication labelDasatinib tablets are indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic…
Why this: Advisory · dailymed-prescription
Dasatinib tablets are indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase. chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib. Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy. Dasatinib tablets are indicated for the treatment of pediatric patients 1 year of age and older with Ph+ CML in chronic phase. newly diagnosed Ph+ ALL in combination with chemotherapy.
- generic_name
- dasatinib
- product_names
- Dasatinib
- ndc
- 73190-046, 0480-5101, 73190-046-60, 73190-047, 0480-5102, 73190-047-60, 73190-048, 0480-5103, 73190-048-60, 73190-049, 0480-3523, 73190-049-30, 73190-050, 0480-5104, 73190-050-30, 73190-051, 0480-3524, 73190-051-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en